河北医科大学学报

• 论著 • 上一篇    下一篇

血清miRNA206,155检测在甲状腺功能亢进缓解后复发中的应用

  

  1. 1.陕西省咸阳市中心医院检验科,陕西 咸阳 712000;2.陕西省石泉县中医医院检验科,陕西 石泉 725200;
    3.西安交通大学第一附属医院检验科,陕西 西安 710061;4.陕西省咸阳市中心医院内分泌科,陕西 咸阳 712000
  • 出版日期:2017-07-25 发布日期:2017-07-05
  • 作者简介:姜彦峰(1974-),男,陕西礼泉人,陕西省咸阳市中心医院主管检验师,医学学士,从事临床检验学研究。

The application of detecting serum miRNA206, 155 in hyperthyroidism relapse after relieving#br#

  1. 1.Department of Laboratory, the Central Hospital of Xianyang City, Shaanxi Province, Xianyang
    712000, China; 2.Department of Laboratory, the Hospital of Chinese Traditional Medicine of
    Shiquan Country, Shaanxi Province, Shiquan 725200, China; 3.Department of Laboratory,
    the First Affiliated Hospital of Xi′An Jiaotong University , Xi′an 710061, China;
    4.Department of Endocrinology, the Central Hospital of Xianyang City,
    Shaanxi Province,Xianyang 712000, China
  • Online:2017-07-25 Published:2017-07-05

摘要: [摘要]〓
〖HTH〗目的〖HTSS〗〖KG*2〗探讨血清miRNA206,155检测在预测甲状腺功能亢进(甲亢)停药后复发中的临床应用价值。
〖HTH〗方法〖HTSS〗〖KG*2〗选择甲亢患者142例,分为未治疗组45例,复发组41例和未复发组56例,采用实时逆转录-聚合酶链反应技术检测各组miRNA206、miRNA155表达水平。采用电化学发光技术检测各组血清三碘甲状原氨酸(triiodothyronine,T3)、甲状腺素(tyroxine,T4)和促甲状腺激素(thyroid stimulating hormone,TSH)水平。通过彩色多普勒超声检测甲状腺上动脉(superior thyroid artery,STA)内径(diameter,D)和收缩期最高血流速度(peak systolic velocity,Vmax)。
〖HTH〗结果〖HTSS〗〖KG*2〗未治疗组和复发组血清T4、T3、STAD和Vmax水平高于未复发组,TSH水平低于未复发组(P<005);未治疗组与复发组间T4、 T3、TSH、STAD和Vmax水平比较差异无统计学意义(P>005)。未治疗组和复发组miRNA155表达水平高于未复发组,miRNA206表达水平低于未复发组(P<005),未治疗组与复发组miRNA155,206表达水平比较差异无统计学意义(P>005)。复发组中miRNA206表达与miRNA155表达呈负相关(r=-0.692,P<001),miRNA206表达与T4、T3、STAD和Vmax水平呈负相关(r=-0.562、-0.593、 -0.537,-0.519,P<001),与TSH呈正相关(r=0.622, P<001);miRNA155表达与血清T4、 T3、STAD和Vmax水平呈正相关(r=0.530、0.562、0.553、0.503,P<001),与TSH呈负相关(r=-0.689,P<001)。miRNA206和miRNA155在最佳临界值处诊断甲亢复发的敏感度和特异度分别为93.2%和90.7%、91.6%和97.2%。
〖HTH〗结论〖HTSS〗〖KG*2〗血清miRNA206,155检测可应用于甲亢停药后复发的预测,并可能成为甲亢治疗有效的预警标志物和干预靶点。

关键词: 甲状腺功能亢进症, 复发, 微RNAs

Abstract: [Abstract]  Objective〖HTSS〗〓To investigate the clinical application value of detecting serum microRNA206, 155 in predicting hyperthyroidism relapse after drug withdrawal.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓The expression levels of serum microRNA206,155 in 142 patients with hyperthyroidism were detected by  technology(45 cases in the nontreatment group, 41 cases in the relapse group and 56 cases in the nonrelapse group) in detecting serum T3, T4 and TSH levels by the electrochemical luminescence technology. The inner diameter(diameter, D) and the maximum systolic blood flow velocity(peak systolic velocity, Vmax) of the superior thyroid artery(superior thyroid, STA) were examined by color Doppler ultrasonography.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓In the relapse group and the nontreatment group, the levels of T4,T3, STAD and Vmax were higher than those in the nonrelapse group, respectively, but TSH were lower(P<005). The levels of T4, T3, TSH, STAD and Vmax between the relapse group and the nontreatment group were compared, but without statistically significant difference(P>005). The expression of miRNA206 was negatively correlated with the expression of miRNA155(r=-0.692, P<001). MiRNA206 expression was negatively correlated with T4, T3, STAD and Vmax(r=-0.562, -0.593, -0.537, -0.519, P<001) and positively correlated with TSH(r=0.622, P<001). The expression of miRNA155 was positively correlated with serum T4, T3, STAD and Vmax(r=0.530, 0.562, 0.553, 0.503, P<001), and negatively correlated with TSH(r=-0.689, P<001). The sensitivity and specificity of miRNA206 and miRNA155 in the diagnosis of hyperthyroidism at the best critical value were 93.2% and 90.7%, 91.6% and 97.2%, respectively.
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓The detection of serum microRNA206, 155 can be used in prediction of hyperthyroidism relapse after discontinuation of medicine treating, and may be an useful warning markers and intervention targets for hyperthyroidism treating.

Key words: hyperthyroidism, recurrence, microRNAs